Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cell ImpactOSTO:CI +0.86% Peter Lynch Fair Value is kr-12.63 as of Jul. 22, 2026. The stock has 7 warning signs investors should review. Among 968 Industrial Products companies, Cell Impact ranks worse than 103305.68% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Cell Impact's PEG is 1. Cell Impact's 5-Year TTM EBITDA Growth Rate is 25.
Cell Impact's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.51. Therefore, the Peter Lynch Fair Value for today is kr-12.63.
As of today (2026-07-22), Cell Impact's share price is kr0.0706. Cell Impact's Peter Lynch fair value is kr-12.63. Therefore, Cell Impact's Price to Peter Lynch Fair Value Ratio for today is N/A.
The historical rank and industry rank for Cell Impact's Peter Lynch Fair Value or its related term are showing as below:
OSTO:CI's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Industrial Products industry.
Industry Median: 1.435 * Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Cell Impact (OSTO:CI) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.
Cell Impact's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
0.0706
/
-12.63
=
N/A
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cell Impact Peter Lynch Fair Value Related Terms
Cell Impact Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for Cell Impact's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:CI vs CRS, ATI, MLI: Peter Lynch Fair Value Comparison
For the Metal Fabrication subindustry, Cell Impact's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cell Impact Price-to-Peter-Lynch-Fair-Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Cell Impact's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Cell Impact's Price-to-Peter-Lynch-Fair-Value falls into.
Cell Impact's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.51.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of kr-12.63 mean?
Cell Impact (OSTO:CI) has a Peter Lynch Fair Value of kr-12.63 as of Jul. 22, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Cell Impact and its competitors. According to the industry distribution chart, Cell Impact ranks #999999 out of 968 companies in the Industrial Products industry.
Is Cell Impact's Peter Lynch Fair Value too high?
Cell Impact's current Peter Lynch Fair Value is kr-12.63. Based on the distribution chart, Cell Impact ranks #999999 out of 968 companies in the Industrial Products industry, which is in the bottom quartile relative to peers.
How does Cell Impact's Peter Lynch Fair Value compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #999999 out of 968 companies for Peter Lynch Fair Value. This places Cell Impact in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for an Industrial Products company?
The median Peter Lynch Fair Value among Industrial Products companies is 1.44, based on 968 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Cell Impact and its competitors. For the Industrial Products industry, the median Peter Lynch Fair Value is 1.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current Peter Lynch Fair Value is kr-12.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.07 — trading 41.2% above its estimated fair value. The current Peter Lynch Fair Value is kr-12.63. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current Peter Lynch Fair Value is kr-12.63 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:CI has been successfully added to your 
